CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in INCY — Incyte Corp
CIK 884546
SAN FRANCISCO, CA
Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$162,743,080
-$8,389,674 QoQ
Shares Held
1,729,102
-0.2% QoQ
Ownership
0.865%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.98849113586127.ToString("F0")%
Shared 0.ToString("F0")%
None 0.011508864138726344.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,184,692,793 across 287 Biotechnology names. INCY ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
This page
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $162,743,080 | 1,729,102 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $171,132,754 | 1,732,639 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $145,596,804 | 1,716,741 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $113,804,497 | 1,671,138 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $101,846,855 | 1,682,029 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $113,486,637 | 1,643,067 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $106,369,442 | 1,609,220 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $75,474,991 | 1,245,051 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $75,482,914 | 1,324,959 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $83,310,651 | 1,326,814 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $71,010,884 | 1,229,200 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $74,324,010 | 1,193,960 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $83,595,287 | 1,156,708 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $88,754,804 | 1,105,015 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $71,927,017 | 1,079,337 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $81,725,183 | 1,075,756 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $87,695,961 | 1,104,205 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $77,611,838 | 1,057,382 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $68,275,292 | 992,662 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $78,011,140 | 927,269 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $72,573,703 | 892,995 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $80,571,922 | 926,327 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $82,791,252 | 922,568 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $94,137,141 | 905,426 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $69,131,023 | 944,026 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||